Fig. 4From: Survival benefits of neoadjuvant chemo(radio)therapy versus surgery first in patients with resectable or borderline resectable pancreatic cancer: a systematic review and meta-analysisSummary of 1-, 3-, and 5-year survival rates in resected patients. a Forest plot of meta-analysis. b Bubble plot using individual hospital data sets. Sizes of circles are proportional to the number of cases. Numbers in parenthesis indicate 95% CIs. Abbreviations: R or RPC, resectable pancreatic cancer; BR or BRPC, borderline resectable pancreatic cancer; NAC(R)T, neoadjuvant chemo(radio)therapy; SF, surgery first; NA, not applicable; YSR, year survival rateBack to article page